JPWO2018091937A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2018091937A5 JPWO2018091937A5 JP2019547794A JP2019547794A JPWO2018091937A5 JP WO2018091937 A5 JPWO2018091937 A5 JP WO2018091937A5 JP 2019547794 A JP2019547794 A JP 2019547794A JP 2019547794 A JP2019547794 A JP 2019547794A JP WO2018091937 A5 JPWO2018091937 A5 JP WO2018091937A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cis
- pharmaceutical
- nutraceutical composition
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP1600629 | 2016-11-17 | ||
| HUP1600629 | 2016-11-17 | ||
| HUP1700196 | 2017-05-05 | ||
| HUP1700196 | 2017-05-05 | ||
| PCT/HU2017/050047 WO2018091937A1 (en) | 2016-11-17 | 2017-11-17 | Precursor compounds for providing retinoids of the vitamin a5 pathway and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020513417A JP2020513417A (ja) | 2020-05-14 |
| JPWO2018091937A5 true JPWO2018091937A5 (enExample) | 2022-12-27 |
| JP7266247B2 JP7266247B2 (ja) | 2023-04-28 |
| JP7266247B6 JP7266247B6 (ja) | 2024-02-15 |
Family
ID=89720182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019547794A Active JP7266247B6 (ja) | 2016-11-17 | 2017-11-17 | ビタミンａ５経路のレチノイド類を提供するための前駆体化合物及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3541783B1 (enExample) |
| JP (1) | JP7266247B6 (enExample) |
| CN (2) | CN116268424B (enExample) |
| AU (1) | AU2017359593B2 (enExample) |
| CA (1) | CA3082441A1 (enExample) |
| ES (1) | ES2967076T3 (enExample) |
| HU (1) | HUE064808T2 (enExample) |
| PL (1) | PL3541783T3 (enExample) |
| WO (1) | WO2018091937A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021038637A1 (ja) * | 2019-08-23 | 2021-03-04 | リファインホールディングス株式会社 | 新規ビタミンａ誘導体およびその製造方法 |
| WO2021197890A1 (en) * | 2020-03-31 | 2021-10-07 | Dsm Ip Assets B.V. | Process for production of vitamin a |
| US20230338305A1 (en) * | 2020-05-06 | 2023-10-26 | Regenall Limited | Vitamin a for use in the treatment of traumatic brain injury |
| CN112522331B (zh) * | 2020-12-09 | 2024-03-22 | 上海克琴科技有限公司 | 一种生物酶催化的羟基频哪酮视黄酸酯的合成方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62248495A (ja) | 1986-04-23 | 1987-10-29 | Mihama Hisaharu | ビタミンａエステルの製法 |
| US5310554A (en) * | 1992-10-27 | 1994-05-10 | Natural Carotene Corporation | High purity beta-carotene |
| CA2164291C (en) | 1993-06-09 | 2007-10-30 | David John Kyle | Methods and pharmaceutical compositions useful for treating neurological disorders |
| US5508456A (en) | 1993-07-30 | 1996-04-16 | Ligand Pharmaceuticals Incorporated | 9-cis tritium-labeled retinoids and intermediates, methods for their synthesis and methods for their use in discovering retinoid X receptor ligands |
| WO1995032946A1 (en) | 1994-05-27 | 1995-12-07 | Ligand Pharmaceuticals Incorporated | Methods for the synthesis of 9-cis retinoids and their novel intermediates |
| GB0103998D0 (en) * | 2001-02-19 | 2001-04-04 | King S College London | Method |
| US20070148106A1 (en) * | 2005-06-15 | 2007-06-28 | Karin Wertz | Treatment, prevention, and modulation of aging of the skin |
| EP1962618A2 (en) * | 2005-12-20 | 2008-09-03 | Alcon Research, Ltd. | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
| US20110082218A1 (en) * | 2006-06-15 | 2011-04-07 | Karin Wertz | Treatment and modulation of gene expression and skin aging |
| US7566795B2 (en) | 2006-10-06 | 2009-07-28 | Eastman Chemical Company | Preparation of retinyl esters |
| CA2774168C (en) | 2009-09-15 | 2021-02-23 | Ronald Erwin Boch | Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle |
| DK2819667T3 (da) | 2012-03-01 | 2020-03-30 | Retinagenix Therapeutics Inc | Retinalderivater til anvendelse til forbedring af synsfunktionen |
| WO2016076454A1 (ko) * | 2014-11-10 | 2016-05-19 | 한국생명공학연구원 | 미생물의 배양방법 및 그 배양미생물로부터 9-시스 베타카로틴의 분리 및 정제방법 |
| US20180170867A1 (en) * | 2015-05-08 | 2018-06-21 | University Of Debrecen | Stereoselective synthesis of 9-cis.13,14-dihydroretinoic acid and its ethyl esters |
-
2017
- 2017-11-17 ES ES17837894T patent/ES2967076T3/es active Active
- 2017-11-17 PL PL17837894.9T patent/PL3541783T3/pl unknown
- 2017-11-17 CA CA3082441A patent/CA3082441A1/en active Pending
- 2017-11-17 WO PCT/HU2017/050047 patent/WO2018091937A1/en not_active Ceased
- 2017-11-17 AU AU2017359593A patent/AU2017359593B2/en active Active
- 2017-11-17 JP JP2019547794A patent/JP7266247B6/ja active Active
- 2017-11-17 CN CN202310088870.8A patent/CN116268424B/zh active Active
- 2017-11-17 EP EP17837894.9A patent/EP3541783B1/en active Active
- 2017-11-17 HU HUE17837894A patent/HUE064808T2/hu unknown
- 2017-11-17 CN CN201780083885.8A patent/CN110337430B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69103636T2 (de) | Biaromatische verbindungen und ihre anwendung in menschen- und tierheilkunde und in der kosmetik. | |
| DE69730330T2 (de) | Verwendung von l-acetylcarnitin, l-isovalerylcarnitin oder l-propionyl-carnitin zur steigerung des igf-spiegels | |
| DE69912790T2 (de) | Farnesyl protein transferase inhibitoren zur behandlung von arthropathien | |
| DE69828881T2 (de) | Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen | |
| DE69428903T2 (de) | Substituierte 2-aminotetraline | |
| DE69205725T2 (de) | Iminoderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Tiermedizin und in der Kosmetik. | |
| US20070105954A1 (en) | Formulation containing a carboxylic acid or an ester thereof | |
| DD259352A5 (de) | Verfahren zur herstellung einer synergistischen kombination von amantadin und selegilin | |
| HUE031712T2 (en) | Retinoids and retinoid-like compounds with positively charged water-soluble prodrugs having very high skin penetration rates | |
| DE69431965T2 (de) | Wirkstoff gegen fettsucht | |
| CN109906218A (zh) | 螺-内酰胺nmda受体调节剂及其用途 | |
| EP1100456A1 (de) | Verwendung von ectoin oder ectoin-derivaten in kosmetischen formulierungen | |
| DE69837564T2 (de) | Azaheterozyklische derivate zur behandlung von haarausfall und neurologischer krankheiten | |
| DE2160148C2 (de) | Arzneimittel und bestimmte Sulfoxide als solche | |
| TWI250872B (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| WO2021144274A1 (fr) | Utilisation de nmn pour la prevention et/ou le traitement d'une douleur articulaire induite par l'activite physique et compositions correspondantes | |
| DE60200895T2 (de) | Verfahren zur Herstellung von reinen Phosphatiden und deren Verwendung in der Kosmetik, im pharmazeutischen Gebiet und im Bereich der Nahrungsmittel | |
| WO2018091937A4 (en) | Precursor compounds for providing retinoids of the vitamin a5 pathway and uses thereof | |
| DE3821317A1 (de) | Thioharnstoffderivate | |
| JPWO2018091937A5 (enExample) | ||
| JP2009062316A (ja) | フラン脂肪酸乃至はその誘導体を含有する皮膚外用剤 | |
| KR101433913B1 (ko) | 글리코실세라마이드 화합물 및 그를 함유한 조성물 | |
| EP4117675A1 (fr) | Utilisation de nicotinamide mononucléotide ou de certains de ses dérivés pour la prevention et/ou le traitement d'une douleur musculaire, ligamentaire ou tendineuse induite par l'activite physique, et compositions correspondantes | |
| US20050191385A1 (en) | Natural product derivatives as food supplements and pharmaceuticals | |
| DE1618849B1 (de) | Phenylisopropylamidverbindungen und Verfahren zu ihrer Herstellung |